Snowman Logistics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 10:05 pm

Competitors of Snowman Logistics Ltd

All Competitor Stocks of Snowman Logistics Ltd

Quarterly Result

Last Updated: August 1, 2025, 11:20 am

Below is a detailed analysis of the quarterly data for Snowman Logistics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 162.70 Cr.. The value appears strong and on an upward trend. It has increased from 137.01 Cr. (Mar 2025) to 162.70 Cr., marking an increase of 25.69 Cr..
• For Expenses, as of Jun 2025, the value is 138.35 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 112.96 Cr. (Mar 2025) to 138.35 Cr., marking an increase of 25.39 Cr..
• For Operating Profit, as of Jun 2025, the value is 24.35 Cr.. The value appears strong and on an upward trend. It has increased from 24.05 Cr. (Mar 2025) to 24.35 Cr., marking an increase of 0.30 Cr..
• For OPM %, as of Jun 2025, the value is 14.97%. The value appears to be declining and may need further review. It has decreased from 17.55% (Mar 2025) to 14.97%, marking a decrease of 2.58%.
• For Other Income, as of Jun 2025, the value is 0.74 Cr.. The value appears strong and on an upward trend. It has increased from 0.33 Cr. (Mar 2025) to 0.74 Cr., marking an increase of 0.41 Cr..
• For Interest, as of Jun 2025, the value is 5.63 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.78 Cr. (Mar 2025) to 5.63 Cr., marking a decrease of 0.15 Cr..
• For Depreciation, as of Jun 2025, the value is 15.51 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.34 Cr. (Mar 2025) to 15.51 Cr., marking an increase of 0.17 Cr..
• For Profit before tax, as of Jun 2025, the value is 3.95 Cr.. The value appears strong and on an upward trend. It has increased from 3.26 Cr. (Mar 2025) to 3.95 Cr., marking an increase of 0.69 Cr..
• For Tax %, as of Jun 2025, the value is 35.44%. The value appears to be increasing, which may not be favorable. It has increased from -19.94% (Mar 2025) to 35.44%, marking an increase of 55.38%.
• For Net Profit, as of Jun 2025, the value is 2.54 Cr.. The value appears to be declining and may need further review. It has decreased from 3.90 Cr. (Mar 2025) to 2.54 Cr., marking a decrease of 1.36 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.15. The value appears to be declining and may need further review. It has decreased from 0.23 (Mar 2025) to 0.15, marking a decrease of 0.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:25 am

Growth

Last Updated: September 5, 2025, 1:31 pm

Balance Sheet

Last Updated: June 16, 2025, 11:19 am

Below is a detailed analysis of the balance sheet data for Snowman Logistics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 167.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 167.00 Cr..
• For Reserves, as of Mar 2025, the value is 240.00 Cr.. The value appears to be declining and may need further review. It has decreased from 251.00 Cr. (Mar 2024) to 240.00 Cr., marking a decrease of 11.00 Cr..
• For Borrowings, as of Mar 2025, the value is 307.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 278.00 Cr. (Mar 2024) to 307.00 Cr., marking an increase of 29.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 58.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 51.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 7.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 771.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 746.00 Cr. (Mar 2024) to 771.00 Cr., marking an increase of 25.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 502.00 Cr.. The value appears to be declining and may need further review. It has decreased from 525.00 Cr. (Mar 2024) to 502.00 Cr., marking a decrease of 23.00 Cr..
• For CWIP, as of Mar 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2024) to 53.00 Cr., marking an increase of 39.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 35.00 Cr..
• For Other Assets, as of Mar 2025, the value is 216.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Mar 2024) to 216.00 Cr., marking an increase of 43.00 Cr..
• For Total Assets, as of Mar 2025, the value is 771.00 Cr.. The value appears strong and on an upward trend. It has increased from 746.00 Cr. (Mar 2024) to 771.00 Cr., marking an increase of 25.00 Cr..

However, the Borrowings (307.00 Cr.) are higher than the Reserves (240.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Snowman Logistics Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 5. It has decreased from 0.76 (Mar 24) to 0.34, marking a decrease of 0.42.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 5. It has decreased from 0.76 (Mar 24) to 0.34, marking a decrease of 0.42.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.12. This value is within the healthy range. It has decreased from 4.31 (Mar 24) to 4.12, marking a decrease of 0.19.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.36. It has decreased from 25.02 (Mar 24) to 24.36, marking a decrease of 0.66.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.36. It has decreased from 25.02 (Mar 24) to 24.36, marking a decrease of 0.66.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 33.07. It has increased from 30.13 (Mar 24) to 33.07, marking an increase of 2.94.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 5.60. This value is within the healthy range. It has decreased from 6.48 (Mar 24) to 5.60, marking a decrease of 0.88.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.82. This value is within the healthy range. It has decreased from 2.94 (Mar 24) to 1.82, marking a decrease of 1.12.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.35. This value is within the healthy range. It has decreased from 1.51 (Mar 24) to 0.35, marking a decrease of 1.16.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 2. It has decreased from 0.76 (Mar 24) to 0.34, marking a decrease of 0.42.
• For PBDIT Margin (%), as of Mar 25, the value is 16.92. This value is within the healthy range. It has decreased from 21.51 (Mar 24) to 16.92, marking a decrease of 4.59.
• For PBIT Margin (%), as of Mar 25, the value is 5.51. This value is below the healthy minimum of 10. It has decreased from 9.74 (Mar 24) to 5.51, marking a decrease of 4.23.
• For PBT Margin (%), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 10. It has decreased from 5.01 (Mar 24) to 1.08, marking a decrease of 3.93.
• For Net Profit Margin (%), as of Mar 25, the value is 1.02. This value is below the healthy minimum of 5. It has decreased from 2.52 (Mar 24) to 1.02, marking a decrease of 1.50.
• For Return on Networth / Equity (%), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 15. It has decreased from 3.03 (Mar 24) to 1.39, marking a decrease of 1.64.
• For Return on Capital Employeed (%), as of Mar 25, the value is 4.52. This value is below the healthy minimum of 10. It has decreased from 7.51 (Mar 24) to 4.52, marking a decrease of 2.99.
• For Return On Assets (%), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has decreased from 1.70 (Mar 24) to 0.73, marking a decrease of 0.97.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.23. This value is within the healthy range. It has increased from 0.14 (Mar 24) to 0.23, marking an increase of 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has increased from 0.22 (Mar 24) to 0.32, marking an increase of 0.10.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.72. It has increased from 0.68 (Mar 24) to 0.72, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 1.30. This value is below the healthy minimum of 1.5. It has decreased from 1.57 (Mar 24) to 1.30, marking a decrease of 0.27.
• For Quick Ratio (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.44 (Mar 24) to 1.15, marking a decrease of 0.29.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 40.73. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 40.73, marking an increase of 40.73.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 293.61. This value exceeds the healthy maximum of 50. It has increased from 131.48 (Mar 24) to 293.61, marking an increase of 162.13.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 24.29. This value is within the healthy range. It has increased from 23.21 (Mar 24) to 24.29, marking an increase of 1.08.
• For Earning Retention Ratio (%), as of Mar 25, the value is -193.61. This value is below the healthy minimum of 40. It has decreased from -31.48 (Mar 24) to -193.61, marking a decrease of 162.13.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 75.71. This value exceeds the healthy maximum of 70. It has decreased from 76.79 (Mar 24) to 75.71, marking a decrease of 1.08.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.82. This value is within the healthy range. It has decreased from 4.55 (Mar 24) to 3.82, marking a decrease of 0.73.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 3. It has decreased from 1.53 (Mar 24) to 1.23, marking a decrease of 0.30.
• For Enterprise Value (Cr.), as of Mar 25, the value is 872.09. It has decreased from 1,309.91 (Mar 24) to 872.09, marking a decrease of 437.82.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 2.60 (Mar 24) to 1.58, marking a decrease of 1.02.
• For EV / EBITDA (X), as of Mar 25, the value is 9.32. This value is within the healthy range. It has decreased from 12.09 (Mar 24) to 9.32, marking a decrease of 2.77.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 2.43 (Mar 24) to 1.35, marking a decrease of 1.08.
• For Retention Ratios (%), as of Mar 25, the value is -193.61. This value is below the healthy minimum of 30. It has decreased from -31.48 (Mar 24) to -193.61, marking a decrease of 162.13.
• For Price / BV (X), as of Mar 25, the value is 1.84. This value is within the healthy range. It has decreased from 2.93 (Mar 24) to 1.84, marking a decrease of 1.09.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 2.43 (Mar 24) to 1.35, marking a decrease of 1.08.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness